Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Regenerative Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Synthetic Material
1.4.3 Biologically Derived Material
1.4.4 Genetically Engineered Material
1.4.5 Others
1.5 Market by Application
1.5.1 Global Regenerative Drugs Market Share by Application (2019-2025)
1.5.2 Cardiovascular
1.5.3 Dermatology
1.5.4 Musculoskeletal
1.5.5 Neurology
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Regenerative Drugs Market Size
2.2 Regenerative Drugs Growth Trends by Regions
2.2.1 Regenerative Drugs Market Size by Regions (2019-2025)
2.2.2 Regenerative Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Regenerative Drugs Market Size by by Players
3.1.1 Global Regenerative Drugs Revenue by by Players (2014-2019)
3.1.2 Global Regenerative Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Regenerative Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Regenerative Drugs Key Players Head office and Area Served
3.3 Key Players Regenerative Drugs Product/Solution/Service
3.4 Date of Enter into Regenerative Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Regenerative Drugs Market Size by Type (2014-2019)
4.2 Global Regenerative Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Regenerative Drugs Market Size (2014-2019)
5.2 Regenerative Drugs Key Players in North America
5.3 North America Regenerative Drugs Market Size by Type
5.4 North America Regenerative Drugs Market Size by Application
6 Europe
6.1 Europe Regenerative Drugs Market Size (2014-2019)
6.2 Regenerative Drugs Key Players in Europe
6.3 Europe Regenerative Drugs Market Size by Type
6.4 Europe Regenerative Drugs Market Size by Application
7 China
7.1 China Regenerative Drugs Market Size (2014-2019)
7.2 Regenerative Drugs Key Players in China
7.3 China Regenerative Drugs Market Size by Type
7.4 China Regenerative Drugs Market Size by Application
8 Japan
8.1 Japan Regenerative Drugs Market Size (2014-2019)
8.2 Regenerative Drugs Key Players in Japan
8.3 Japan Regenerative Drugs Market Size by Type
8.4 Japan Regenerative Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Regenerative Drugs Market Size (2014-2019)
9.2 Regenerative Drugs Key Players in Southeast Asia
9.3 Southeast Asia Regenerative Drugs Market Size by Type
9.4 Southeast Asia Regenerative Drugs Market Size by Application
10 India
10.1 India Regenerative Drugs Market Size (2014-2019)
10.2 Regenerative Drugs Key Players in India
10.3 India Regenerative Drugs Market Size by Type
10.4 India Regenerative Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Regenerative Drugs Market Size (2014-2019)
11.2 Regenerative Drugs Key Players in Central & South America
11.3 Central & South America Regenerative Drugs Market Size by Type
11.4 Central & South America Regenerative Drugs Market Size by Application
12 International Players Profiles
12.1 Stryker
12.1.1 Stryker Company Details
12.1.2 Company Description and Business Overview
12.1.3 Regenerative Drugs Introduction
12.1.4 Stryker Revenue in Regenerative Drugs Business (2014-2019))
12.1.5 Stryker Recent Development
12.2 Zimmer Biomet Holdings
12.2.1 Zimmer Biomet Holdings Company Details
12.2.2 Company Description and Business Overview
12.2.3 Regenerative Drugs Introduction
12.2.4 Zimmer Biomet Holdings Revenue in Regenerative Drugs Business (2014-2019)
12.2.5 Zimmer Biomet Holdings Recent Development
12.3 Medtronic
12.3.1 Medtronic Company Details
12.3.2 Company Description and Business Overview
12.3.3 Regenerative Drugs Introduction
12.3.4 Medtronic Revenue in Regenerative Drugs Business (2014-2019)
12.3.5 Medtronic Recent Development
12.4 Athersys
12.4.1 Athersys Company Details
12.4.2 Company Description and Business Overview
12.4.3 Regenerative Drugs Introduction
12.4.4 Athersys Revenue in Regenerative Drugs Business (2014-2019)
12.4.5 Athersys Recent Development
12.5 STEMCELL Technologies
12.5.1 STEMCELL Technologies Company Details
12.5.2 Company Description and Business Overview
12.5.3 Regenerative Drugs Introduction
12.5.4 STEMCELL Technologies Revenue in Regenerative Drugs Business (2014-2019)
12.5.5 STEMCELL Technologies Recent Development
12.6 Organogenesis
12.6.1 Organogenesis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Regenerative Drugs Introduction
12.6.4 Organogenesis Revenue in Regenerative Drugs Business (2014-2019)
12.6.5 Organogenesis Recent Development
12.7 Integra Lifesciences
12.7.1 Integra Lifesciences Company Details
12.7.2 Company Description and Business Overview
12.7.3 Regenerative Drugs Introduction
12.7.4 Integra Lifesciences Revenue in Regenerative Drugs Business (2014-2019)
12.7.5 Integra Lifesciences Recent Development
12.8 Acelity
12.8.1 Acelity Company Details
12.8.2 Company Description and Business Overview
12.8.3 Regenerative Drugs Introduction
12.8.4 Acelity Revenue in Regenerative Drugs Business (2014-2019)
12.8.5 Acelity Recent Development
12.9 Isto Biologics
12.9.1 Isto Biologics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Regenerative Drugs Introduction
12.9.4 Isto Biologics Revenue in Regenerative Drugs Business (2014-2019)
12.9.5 Isto Biologics Recent Development
12.10 CryoLife
12.10.1 CryoLife Company Details
12.10.2 Company Description and Business Overview
12.10.3 Regenerative Drugs Introduction
12.10.4 CryoLife Revenue in Regenerative Drugs Business (2014-2019)
12.10.5 CryoLife Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Stryker、Zimmer Biomet Holdings、Medtronic、Athersys、STEMCELL Technologies、Organogenesis、Integra Lifesciences、Acelity、Isto Biologics、CryoLife